Posted On: 09/18/2015 5:56:47 PM
Post# of 92
AEZS cancer drug founder got Nobel Prize in Medicine
1) Zoptarelin doxorubicin was developed by Andrew V. Schally while at the Tulane University School of Medicine, New Orleans and subsequently at the Sylvester Comprehensive Cancer Center, University of Miami.
The U.S. Food and Drug Administration (FDA) has granted it orphan drug status for ovarian cancer and endometrial cancer.
https://en.wikipedia.org/wiki/Zoptarelin_doxorubicin
About Andrew Schally
Andrzej Viktor "Andrew" Schally (born November 30, 1926) is a Polish-American endocrinologist and Nobel Prize laureate (1977) in medicine, sharing the prize that year with Roger Guillemin and Rosalyn Sussman Yalow.
https://en.wikipedia.org/wiki/Andrew_Schally
2) AEZS~ August 25, NEW presentation!
http://www.aezsinc.com/pdfdyn/AEZS%20Presenta...-FINAL.pdf
https://en.wikipedia.org/wiki/Zoptarelin_doxorubicin
http://clincancerres.aacrjournals.org/content/20/24/6277
1) Zoptarelin doxorubicin was developed by Andrew V. Schally while at the Tulane University School of Medicine, New Orleans and subsequently at the Sylvester Comprehensive Cancer Center, University of Miami.
The U.S. Food and Drug Administration (FDA) has granted it orphan drug status for ovarian cancer and endometrial cancer.
https://en.wikipedia.org/wiki/Zoptarelin_doxorubicin
About Andrew Schally
Andrzej Viktor "Andrew" Schally (born November 30, 1926) is a Polish-American endocrinologist and Nobel Prize laureate (1977) in medicine, sharing the prize that year with Roger Guillemin and Rosalyn Sussman Yalow.
https://en.wikipedia.org/wiki/Andrew_Schally
2) AEZS~ August 25, NEW presentation!
http://www.aezsinc.com/pdfdyn/AEZS%20Presenta...-FINAL.pdf
https://en.wikipedia.org/wiki/Zoptarelin_doxorubicin
http://clincancerres.aacrjournals.org/content/20/24/6277
(0)
(0)
